Hi ,

Our advance pricing for SynBioBeta ends at midnight this Friday!  

This week’s digest is brought to you by LatchBio, a San Francisco-based company on a mission to build and disseminate the data infrastructure for the biocomputing revolution. The company’s cloud-based platform offers no-code bioinformatics for scientists seeking to store, transform and visualize their data. Through any web browser, the global scientific community can quickly access popular bioinformatics pipelines and data visualization tools.

Meet the Latest SynBioBeta Speakers!

Making a Big Announcement at SynBioBeta this year?

2024 Exhibitors and Sponsors: Take advantage of the opportunity we have to get in front of journalists from outlets like The Economist, Forbes, The New Yorker, Wired, STAT, GEN, GenomeWeb, and many more. The deadline for sending headlines and embargoed news to be included in the 2024 Media Kit is 5 pm MT on Monday, April 1st. Please send to Katie Orrell.

New Sponsors & Exhibitors:

• SynbiCITE is a unique collaboration of the UK’s leading academic institutions and industrial partners, ranging from start-ups to large multinational companies.

• The Bioindustry Association (BIA) is the voice of the life sciences and biotech industry in the UK, connecting businesses to enable growth and innovation.

• NPL is the UK's National Metrology Institute, providing the measurement capability that underpins the UK's prosperity and quality of life.

• IBioIC is a networking and support organization that connects industry, academia, and government to bring biotechnology processes and products to the global market.

• Asymchem is a CDMO company driving innovation in complex chemistry while elevating excellence with a commitment to quality and regulatory compliance.

• Bio Base Europe Pilot Plant is an independent, state-of-the-art facility that operates from a laboratory level to a multi-ton scale.

• Beckman Coulter Life Sciences is a Danaher company focusing on healthcare through discovery, research, and more.

• Elemental Machines’ Intelligent Operations Platform leverages the best Internet of Things (IoT) technology and custom hardware/software solutions, delivering actionable insights to operators in life sciences, biopharma labs, biobanks, analytical labs, and manufacturing facilities.

• Pow.Bio's high-efficiency fermentation platform decouples growth and production, solving the problems of contamination and genetic drift.

• RTA Consulting is a people-as-a-service organization bringing world-class organizational development, strategic and tactical HR, and exceptionally strong talent acquisition capabilities to start-up and mid-sized companies.

New Partnerships:

• IndieBio is a program of SOSV, a global venture capital firm providing multi-stage investment to support big ideas.

• California Life Sciences is California's most influential and impactful life sciences membership organization.

• Foresight Institute is advancing science and technology for long-term, flourishing futures by creating community, promoting beneficial uses, and reducing potential misuse and harm.

• Lifespan.io’s mission is to promote the advancement of biomedical technologies which will increase healthy human lifespan and eliminate age-related diseases.

As the excitement builds for SynBioBeta 2024, we invite everyone to attend our engaging conference preview Zoom call on Wed 4/3 @ 9 am PT. This is a fantastic opportunity to meet some of our Track Chairs, learn about exclusive networking opportunities, ask questions about the agenda, and set the stage for a successful conference!  RSVP

If you’d like to drive more business to your company, consider joining the exhibit hall floor, by contacting Anissa Cooke.

New Podcast Episode

• Want to learn a little more about Decentralized Science from our conference track Chair and cofounder of DeSci London, Alfred Brown? Then check out the latest episode of The Inside Track, where our own Fiona Mischel sat down with Alfred to discuss how DeSci can accelerate critical projects like orphan disease research and transform scientific publishing. A fun chat that’s not to be missed!

Insights (Exclusive Content):

• Personal Hygiene’s Renaissance, Brought to You by Synthetic Biology: With a recent $2.5M in funding, Taxa Technologies is employing a consumer-first approach and leveraging microbiome technology to create improved, less toxic personal care products.

• Designing Programmable Cancer Therapies with Synthetic Gene Circuits: Synthetic gene circuits make cancers more visible to immunotherapies while minimizing their toxicity and adverse effects.

Industry News:

• The Buzz in Food Tech: MeliBio's AI-Enhanced Honey Alternatives. MeliBio scales up its precision fermentation technology, promising a new era of sustainable, bee-friendly honey alternatives.

• Profluent Secures $35M Funding Led by Spark Capital to Advance AI-First Protein Design. Profluent, an AI-centric company focused on protein design, has announced the completion of additional funding, bringing their total capital raised to $44 million.

• Yeast Proves Itself a Budding Star in Human Artificial Chromosome Construction. A novel technique employing budding yeast has enabled the construction of stable human artificial chromosomes (HACs), addressing longstanding issues with uncontrolled multimerization.

• The Four-Day Meat Miracle by Meatable. The company’s cell production time is reduced by 50%, significantly increasing efficiency and enhancing the sustainability of the industrial process.

Additional Industry News:

• Capstan Therapeutics, a biotechnology company dedicated to advancing in vivo reprogramming of cells through RNA delivery using targeted lipid nanoparticles (tLNP), announced the successful closing of a $175M oversubscribed Series B financing. (Press release)

• Imagindairy and Ginkgo Bioworks Collaborate to Develop and Produce Animal-Free Non-Whey Dairy Proteins. (Press release)

• Modern Meadow and Stone Island Announce Breakthrough in Textile Innovation Using Biofabrication for SS24: Modern Meadow's proprietary Bio-Alloy™ technology platform is used on new versions of Stone Island Raso Gommato fabric for men's coats. (Press release)

David Williamson. President & COO of Modern Meadow.

• Technip Energies and LanzaTech Selected by the US Department of Energy to Receive $200M Investment for Breakthrough, Replicable Decarbonized Ethylene Commercial Facility. (Press release)

• Tierra Biosciences Secures $11.4M Series A Funding Round Led by Material Impact Company to Provide Broader Access to its AI-Driven Cell-Free Protein Production Platform. (Press release)

• The White House Advances Biotechnology and Biomanufacturing Leadership with the Launch of the National Bioeconomy Board. (Press release)

• Intellia Therapeutics Announces First Patient Dosed in the Phase 3 MAGNITUDE Study of NTLA-2001 as a Single-Dose CRISPR-Based Treatment for Transthyretin Amyloidosis with Cardiomyopathy. (Press release)

• Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office. (Press release)

• It's Time To Dethrone CHO When It Comes To mAb Production: The high cost of production, limited ability to scale, and the entrenchment of CHO cell-specific manufacturing infrastructures for antibody-based drugs preclude broader access to these drugs. (Bioprocess Online)

• Oobli Becomes First Company to Receive FDA "No Questions" Letter for a Novel Sweet Protein Produced via Precision Fermentation. (Press release)

• First pig kidney transplant in a person: what it means for the future. The operation's early success has made researchers hopeful that clinical trials for xenotransplanted organs will start soon. (Nature News)

Who's hiring?

• Senior Applications Scientist at Elegen (San Carlos, CA)

• Senior Bioinformatics Developer at Elegen (San Carlos, CA)